Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction

Circulation - United States
doi 10.1161/circulationaha.106.616219
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Use of Nonsteroidal Anti-Inflammatory Drugs and the Risk of First-Time Acute Myocardial Infarction

British Journal of Clinical Pharmacology
Pharmacology
2002English

Relationship Between Selective Cyclooxygenase-2 Inhibitors and Acute Myocardial Infarction in Older Adults

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Reduction in Cancer Risk by Selective and Nonselective Cyclooxygenase-2 (COX-2) Inhibitors

Journal of Experimental Pharmacology
Molecular MedicinePharmacology
2012English

Effects of Selective Cyclooxygenase-2 and Nonselective Cyclooxygenase Inhibition on Ischemic Myocardium

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2010English

Comparison of Nonsteroidal Anti-Inflammatory Drugs and Cyclooxygenase-2 (COX-2) Inhibitors Use in Australia and Nova Scotia (Canada)

British Journal of Clinical Pharmacology
Pharmacology
2009English

Use of Nicotine Replacement Therapy and the Risk of Acute Myocardial Infarction, Stroke, and Death

Tobacco Control
EnvironmentalPublic HealthHealthOccupational Health
2005English

Colonic Side Effects of Nonsteroidal Antiinflammatory Drugs

Internal Medicine
Internal MedicineMedicine
1999English

Discontinuation of Nonsteroidal Anti-Inflammatory Drug Therapy and Risk of Acute Myocardial Infarction

Archives of Internal Medicine
2004English

Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis

Archives of Internal Medicine
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy